BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38743659)

  • 1. IgG subclass levels in referred hemochromatosis probands with HFE p.C282Y/p.C282Y.
    Barton JC; Barton JC; Bertoli LF; Acton RT
    PLoS One; 2024; 19(5):e0302817. PubMed ID: 38743659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y.
    Barton JC; Bertoli LF; Acton RT
    Blood Cells Mol Dis; 2003; 31(1):102-11. PubMed ID: 12850493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 6p SNP microhaplotypes and IgG3 levels in hemochromatosis probands with HFE p.C282Y homozygosity.
    Barton JC; Barton JC; Cruz E; Teles MJ; Guimarães JT; Porto G
    Blood Cells Mol Dis; 2020 Nov; 85():102461. PubMed ID: 32623342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.
    Barton JC; Barton JC; Acton RT
    BMC Gastroenterol; 2023 Apr; 23(1):137. PubMed ID: 37118679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer survival associated with HLA-A*03, B*14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping.
    Barton JC; Barton JC; Acton RT
    Eur J Haematol; 2010 Nov; 85(5):439-47. PubMed ID: 20722701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity.
    Barton JC; Barton JC; Acton RT
    Hereditas; 2022 Jun; 159(1):25. PubMed ID: 35659379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet counts in
    Barton JC; Barton JC; Acton RT
    Platelets; 2023 Dec; 34(1):2217933. PubMed ID: 37260121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Height of non-Hispanic white adults with homeostatic iron regulator HFE genotypes p.C282Y/p.C282Y and wt/wt.
    Barton JC; Barton JC; Acton RT
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2321. PubMed ID: 37930135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with IgG levels in adults with IgG subclass deficiency.
    Barton JC; Barton JC; Bertoli LF; Acton RT
    BMC Immunol; 2021 Aug; 22(1):53. PubMed ID: 34372773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
    Barton JC; Barton EH; Acton RT
    BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content.
    Barton JC; Bertoli LF; Rothenberg BE
    J Lab Clin Med; 2000 Jan; 135(1):96-104. PubMed ID: 10638700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives.
    Barton JC; Barton JC
    J Immunol Res; 2015; 2015():453046. PubMed ID: 26504855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.
    Barton JC; Barton JC; Patel N; McLaren GD
    PLoS One; 2021; 16(12):e0261690. PubMed ID: 34932603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes in first-degree family members: a predictor of type 2 diabetes in 159 nonscreening Alabama hemochromatosis probands with HFE C282Y homozygosity.
    Barton JC; Barton JC; Acton RT
    Diabetes Care; 2014; 37(1):259-66. PubMed ID: 23990522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
    McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
    Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study.
    Barton JC; Leiendecker-Foster C; Reboussin DM; Adams PC; Acton RT; Eckfeldt JH;
    Thyroid; 2008 Aug; 18(8):831-8. PubMed ID: 18651828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White blood cells and subtypes in HFE p.C282Y and wild-type homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Barton JC; Barton JC; Acton RT
    Blood Cells Mol Dis; 2017 Mar; 63():9-14. PubMed ID: 27915113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.